Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.79	29.83	47.19
Graham Fair Price	14.32	55.08	48.18
PEG	-27.92	0.62	-0.87
Price/Book	17.86	5.71	4.84
Price/Cash Flow	48.67	31.83	21.41
Prices/Earnings	-4.16	16.83	17.57
Price/Sales	7.13	9.21	8.60
Price/FCF	48.67	31.83	21.41
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.00	0.62	0.57
Operating Margin	76.20	0.28	0.16
ROA	22.26	< 0.005	< 0.005
ROE	0.07	0.08	22.97
ROIC	0.03	0.05	94.78
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.02	25.34
Dividends QOQ	< 0.005	< 0.005	-16.76
EBIT QOQ	-0.19	0.99	420.49
EPS QOQ	-0.20	0.27	32.97
FCF QOQ	-0.19	-0.19	2.07
Revenue QOQ	0.03	0.13	335.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	623.96	0.00	inf
Days Sales Outstanding (DSO)	364.23	301.28	-17.28
Inventory Turnover	0.14	0.00	inf
Debt/Capitalization	0.64	0.64	0.12
Quick Ratio	7.79	0.76	-90.23
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.70	39.89	3.09
Cash	66.63	75.19	12.85
Capex	-0.59	-0.55	6.29
Free Cash Flow	8.75	7.15	-18.28
Revenue	21.78	24.70	13.41
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.35	0.36	-89.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.90	-0.66	-25.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating